<DOC>
	<DOCNO>NCT01105702</DOCNO>
	<brief_summary>This pilot phase II trial study well give temozolomide , bevacizumab , lithium carbonate , radiation therapy work treat patient newly diagnose high grade glioma .</brief_summary>
	<brief_title>Temodar ( Temozolomide ) , Bevacizumab , Lithium Radiation High Grade Glioma</brief_title>
	<detailed_description>Treatment high grade glioma ( HGG ) anti-angiogenic therapy result clinical improvement prolong progression-free survival ( PFS ) . However , mant patient experience diffuse recurrence treatment failure . This phase II trial test feasibility add lithium carbonate , previously show anti-invasive property HGG , bevacizumab chemoradiation follow surgical resection HGG .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Newly diagnose high grade glioma ( WHO Grade III IV ) Brain magnetic resonance imaging ( MRI ) scan gadolinium contrast Patient must normal organ marrow function define : Absolute neutrophil count &gt; = 1,500/mm^3 ; Platelet count &gt; =100,000/mm^3 ; Hemoglobin &gt; = 10g/dL ; Blood urea nitrogen serum creatinine = &lt; 1.5 time upper limit normal ( ULN ) ; Total bilirubin = &lt; 1.5 time ULN ; SGOT SGPT = &lt; 3 time ULN ; Alkaline phosphatase = &lt; 2 time ULN . &gt; =18 year age ; Karnofsky Performance Score &gt; = 70 ; Life expectancy &gt; = 8 week ; Negative serum urine betahCG pregnancy test screening patient child bear potential ; Men woman reproductive potential must agree use acceptable method birth control ( surgical , hormonal double barrier , ie , condom diaphragm ) treatment 6 month completion treatment ; Patient legal proxy must provide write informed consent prior registration study ; Residual measurable disease . Current , recent ( within 4 week first infusion study ) , plan participation experimental drug study ; Prior radiation therapy brain ; Prior treatment Chemotherapy Targeted agent Previous ( within last 5 year ) current malignancy sit except adequately treat basal cell squamous cell skin cancer situ carcinoma cervix ; ( Uncontrolled High blood pressure &gt; 150/100 Common Terminology Criteria Adverse Event 3.0 &gt; = Grade 2 congestive heart failure ( CHF ) ; History myocardial infarction within 6 month ; History stroke within 6 month ; Clinically significant peripheral vascular disease ; Evidence bleed diathesis coagulopathy ; Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior first dose bevacizumab anticipation need major surgical procedure course study ; Minor surgical procedure , fine needle aspiration core biopsy within 7 day prior study enrollment ; Urine protein/Creatinine ratio &gt; = 2.0 screening ; Serious , nonhealing wound , ulcer , bone fracture ; Inability comply study and/or followup procedure ; Glioma show active intratumoral bleeding ; Patients enzymeinducing antiepileptic drug ; Known Positive HIV1 , hepatitis B surface antigen , hepatitis C antibody ; Medications like nonsteroidal antiinflammatory drug , antipsychotic , iodide , angiotensinconverting enzyme inhibitor , If receiving , must discontinue 7 day prior initiate lithium ; Any previous cytotoxic drug therapy , exclude corticosteroid temozolomide concurrent radiation therapy ; Any known genetic cancersusceptibility syndrome ; Acute infection : active viral , bacterial , fungal infection require specific therapy . Active uncontrolled infection example include sexually transmitted disease , herpes , scrofula , malaria , etc . ; Fever &gt; 101.5 degree Fahrenheit ; Unstable severe intercurrent medical condition unstable angina , uncontrolled arrythmias , Crohn 's disease , ulcerative colitis , psoriasis , etc . ; Implantation Gliadel wafer surgery ; Patients organ allograft ; Allergies reagent use study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>brain tumor</keyword>
	<keyword>brain cancer</keyword>
	<keyword>glioma</keyword>
</DOC>